333D’s directors are committed to upholding strong standards of corporate governance and social responsibility and creating value for shareholders.
Dr. Nigel Finch
Dr. Nigel Finch is a company director and advisor with experience working with early stage and emerging ASX-listed companies. He is managing director of Saki Partners which assists clients with strategy execution and financial performance.
Mr John Conidi has over 20 years experience developing, acquiring and managing businesses in healthcare and tech, with a focus on diagnostic imaging, 3D printing and AI. Mr Conidi has a further 10 years as managing director of an ASX 300 company involved in operations, M&A, capital raising and debt financing.
Dr. Richard Petty
Dr Richard Petty has served on a number of boards both public and private companies. He has advised on significant projects and investments across a wide range of industries. Dr. Petty has been professor at several universities. He holds several degrees, including a PhD.
333D Limited is committed to sound corporate governance and to this end, a corporate governance framework has been, and continues to be, developed and is designed to comply with the practices set out in the ASX Corporate Governance Guidelines.
333D Limited's key corporate governance documents can be viewed by clicking below: